Endovascular Abdominal Aortic Aneurysm Repair Clinical Trial
Official title:
Contrast Ultrasound in the Surveillance of Endovascular Abdominal Aortic Aneurysm Repair
Verified date | March 2012 |
Source | Ottawa Hospital Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Observational |
The purpose of this study is to support the suspected expectation that Contrast enhanced
Ultrasound (CUS) detects all endoleaks that have been detected by Computed Tomography (CT),
and also find a number of leaks missed by CT.
The investigators' primary goal is to detect no difference between CT and CUS and provide
evidence that CUS is a possible alternative to CT.
Status | Completed |
Enrollment | 140 |
Est. completion date | March 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - All patients who underwent EVAR at The Ottawa Hospital and currently under post-EVAR surveillance at The Ottawa Hospital. Exclusion Criteria: - Unable to consent for injection of contrast - Unable to acquire IV access - Right-to-left, bi-directional, or transient right-to-left cardiac shunts - Severe pulmonary disease - Previous hypersensitivity to DEFINITY® or its components - Unable to be followed as a outpatient by the Vascular Diagnostic Center |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ottawa Hospital Research Institute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03993496 -
Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair
|